Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/13625187.2020.1867845 http://scihub22266oqcxt.onion/10.1080/13625187.2020.1867845 33475429!ä!33475429       Eur+J+Contracept+Reprod+Health+Care 2021 ; 26 (2): 128-131 Nephropedia Template TP {{tp|p=33475429|t=2021. Combined hormonal contraception and COVID-19 |pdf=|usr=}}{{33475429}} gab.com Text Combined hormonal contraception and COVID-19 JO: Eur J Contracept Reprod Health Care http://www.kidney.de/pget.php?&tw=1&pmid=33475429 #FOAvip Aim: This article reviews the possibility of using combined hormonal contraception during the COVID-19 pandemic. Methods: narrative reviewResults: The factors that protect women from the severity of the disease are analysed, as well as the risk factors for the use of this type of contraception, especially related to the increased risk of a thrombotic event in patients affected by the disease. Finally, the information available on the guidelines for action in patients with COVID-19 using combined hormonal contraception is collected.Conclusions: We can continue to prescribe and use hormonal methods with EE. Twit Text FOAVip Combined hormonal contraception and COVID-19 ????Eur J Contracept Reprod Health Care http://www.kidney.de/pget.php?&tw=1&pmid=33475429 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33475429 #FOAvip English Wikipedia <ref>{{Cite pmid|33475429}}</ref> Combined hormonal contraception and COVID-19 #MMPMID33475429 Lete I Eur J Contracept Reprod Health Care 2021[Apr]; 26 (2): 128-131 PMID33475429show ga Aim: This article reviews the possibility of using combined hormonal contraception during the COVID-19 pandemic. Methods: narrative reviewResults: The factors that protect women from the severity of the disease are analysed, as well as the risk factors for the use of this type of contraception, especially related to the increased risk of a thrombotic event in patients affected by the disease. Finally, the information available on the guidelines for action in patients with COVID-19 using combined hormonal contraception is collected.Conclusions: We can continue to prescribe and use hormonal methods with EE. |COVID-19/blood/*immunology[MESH] |Contraceptive Agents, Hormonal/blood/*therapeutic use[MESH] |Female[MESH] |Hormonal Contraception/*methods[MESH] |Humans[MESH] |Protective Factors[MESH] |Risk Factors[MESH] |SARS-CoV-2/immunology[MESH]Combined hormonal contraception and COVID-19 (epmc).pdf DeepDyve Pubget Overpricing